Virtual drug quiets noise in heart tissue images

This image shows the microtissues from Nate Huebsch’s lab that are stained for cell nuclei (blue), sarcomeric alpha-actinic (red) and Myosin Binding Protein C (MYBPC3; green). Mutations in MYBPC3 cause hypertrophic cardiomyopathy. These sarcomere structures are disrupted by chemical blebbistatin.
Credit: Huebsch lab, Washington University in St. Louis

Researchers at Washington University in St. Louis have developed a new computational approach to removing movement in images of expanding and contracting heart cells and tissues. By computationally removing movement, the algorithm mimics a drug’s action in stopping the heart, without compromising cellular structure or tissue contractility.

Results of the research, led by Nathaniel Huebsch, an assistant professor of biomedical engineering, and Guy Genin, the Harold and Kathleen Faught Professor of Mechanical Engineering, both at the McKelvey School of Engineering, are published in the Sept. 11 Proceedings of the National Academy of Sciences.

“When the heart beats, the electrical signal goes through the tissue, and that triggers mechanical squeezing,” said Huebsch, who studies how mechanical cues affect heart development and disease. “In many cases, deadly arrhythmias happen because the electric pulse becomes decoupled from the mechanical squeezing. Our group leverages biomaterials and genetics to study how inherited cardiomyopathies develop, and we are very excited to have a tool that allows us, for the first time, to directly and non-invasively study electro-mechanical coupling in cardiomyocytes.”

The team’s algorithm mimics the action of blebbistatin, a drug that inhibits motion of heart muscle but also can negatively impact the underlying structure of these cells.

This so-called virtual blebbistatin was created from two algorithms: one that has been successful in estimating displacements for cardiac mapping; and another that uses the first to map evolving signals back to a stabilized image of the tissue. The approach allows researchers to directly monitor the coupling of calcium waves, membrane voltage and mechanical contraction beat by beat in heart tissue models, giving insight into diseases of the heart.

Read more on the McKelvey School of Engineering website.

Journal: Proceedings of the National Academy of Sciences
DOI: 10.1073/pnas.2212949120
Article Title: Virtual blebbistatin: A robust and rapid software approach to motion artifact removal in optical mapping of cardiomyocytes
Article Publication Date: 15-Sep-2023

Media Contact

Talia Ogliore
Washington University in St. Louis
talia.ogliore@wustl.edu
Office: 314-935-2919

www.wustl.edu

Media Contact

Talia Ogliore
Washington University in St. Louis

All latest news from the category: Medical Engineering

The development of medical equipment, products and technical procedures is characterized by high research and development costs in a variety of fields related to the study of human medicine.

innovations-report provides informative and stimulating reports and articles on topics ranging from imaging processes, cell and tissue techniques, optical techniques, implants, orthopedic aids, clinical and medical office equipment, dialysis systems and x-ray/radiation monitoring devices to endoscopy, ultrasound, surgical techniques, and dental materials.

Back to home

Comments (0)

Write a comment

Newest articles

World’s first method

Successful surgery for a rare congenital heart disease “scimitar syndrome”. Scimitar syndrome, a rare congenital heart disease, involves an anomalous pulmonary venous return where the right pulmonary veins return to…

Improving HIV treatment in children and adolescents – the right way!

Globally, around 2.6 million children and adolescents are currently living with HIV, the majority of them in Africa. These young people are much more likely to experience treatment failure than…

Study shows promise for a universal influenza vaccine

OHSU-led research uses innovative vaccine platform to target interior of virus; scientists validate theory using 1918 flu virus. New research led by Oregon Health & Science University reveals a promising…

Partners & Sponsors